Director, Nucleic Acid Delivery

Lila Sciences Lila Sciences · AI Frontier · One Charles Park, Cambridge, MA · Autonomous Science Platform

This role leads the discovery and engineering of next-generation nucleic acid delivery systems using the Lila Sciences AI platform and AI Science Factory. The Director will guide a team in integrating AI-driven hypothesis generation, robotics-enabled experimentation, and biological insight to accelerate discovery of transformative delivery technologies, focusing on biological targeting and functional delivery.

What you'd actually do

  1. Lead and build a high-performing team of senior scientists, scientists, and research associates focused on nucleic acid delivery technology development.
  2. Drive the discovery and engineering of targeted lipid nanoparticle systems for delivery of nucleic acid therapeutics.
  3. Design and evaluate targeting ligands, conjugation strategies, and nanoparticle architectures that enable tissue- and cell-specific delivery.
  4. Develop and implement innovative biological assays and screening platforms to evaluate delivery efficiency, biodistribution, cellular uptake, and functional nucleic acid expression or editing.
  5. Leverage the Lila AI platform and AI Science Factory to accelerate design–build–test–learn cycles through AI-driven experimental design and robotics-enabled experimentation.

Skills

Required

  • PhD in molecular biology, bioengineering, chemical biology, biomedical engineering, pharmacology, or a related discipline with 8–10+ years of relevant industry or academic experience, or a BS/MS with 12–15+ years of experience in nucleic acid delivery or genetic medicine.
  • Demonstrated expertise in lipid nanoparticle technologies, nucleic acid delivery systems, or related genetic medicine platforms.
  • Strong track record of scientific leadership and mentorship, including managing multidisciplinary research teams.
  • Experience designing and executing in vitro and in vivo assays to measure delivery efficiency, biodistribution, and functional activity of nucleic acid therapeutics.
  • Deep understanding of the biological mechanisms underlying delivery, including cellular uptake, endosomal escape, tissue targeting, and intracellular trafficking.
  • Experience collaborating across disciplines including formulation chemistry, molecular biology, protein engineering, and pharmacology.
  • Track record of impactful scientific contributions demonstrated through publications, patents, or therapeutic development programs.

Nice to have

  • Direct experience developing targeted LNP systems or ligand-directed nanoparticle delivery technologies.
  • Expertise in RNA therapeutics, gene editing systems (e.g., CRISPR/Cas), siRNA, mRNA, or DNA therapeutics.
  • Experience integrating AI-driven discovery tools, high-throughput experimentation, or automated laboratory platforms into biological research.
  • Experience working in highly collaborative environments spanning biology, chemistry, computational science, and engineering.
  • Demonstrated ability to translate early discovery concepts into therapeutically relevant delivery platforms.
  • Entrepreneurial mindset with a passion for pushing the boundaries of AI-enabled scientific discovery.

What the JD emphasized

  • discovery and engineering of targeted lipid nanoparticle systems
  • targeting ligands, conjugation strategies, and nanoparticle architectures
  • innovative biological assays and screening platforms
  • Lila AI platform and AI Science Factory
  • biological targeting strategies with lipid chemistry and nanoparticle formulation optimization
  • next-generation delivery modalities
  • 8–10+ years of relevant industry or academic experience
  • BS/MS with 12–15+ years of experience
  • lipid nanoparticle technologies, nucleic acid delivery systems, or related genetic medicine platforms
  • in vitro and in vivo assays to measure delivery efficiency, biodistribution, and functional activity of nucleic acid therapeutics
  • biological mechanisms underlying delivery, including cellular uptake, endosomal escape, tissue targeting, and intracellular trafficking
  • formulation chemistry, molecular biology, protein engineering, and pharmacology
  • publications, patents, or therapeutic development programs
  • targeted LNP systems or ligand-directed nanoparticle delivery technologies
  • RNA therapeutics, gene editing systems (e.g., CRISPR/Cas), siRNA, mRNA, or DNA therapeutics
  • AI-driven discovery tools, high-throughput experimentation, or automated laboratory platforms
  • AI-enabled scientific discovery

Other signals

  • AI-driven hypothesis generation
  • robotics-enabled experimentation
  • AI platform
  • AI Science Factory